New HPV vaccine trial aims to protect kids and teens from cancer
NCT ID NCT07377656
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a bivalent HPV vaccine in healthy infants (9 months), toddlers (15 months), children (2-5 years), and unmarried young women (15-20 years) in Ghana. Researchers want to see if the vaccine is safe and triggers a strong immune response, especially when given alongside routine childhood vaccines. The trial is still recruiting and will compare vaccinated groups to a placebo group.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
bivalent human papillomavirus (HPV) vaccine
What this could lead to
If successful, this could help protect young children and women against HPV-related cancers, potentially simplifying vaccination schedules.
What could go wrong
This is an early phase 2 proof-of-concept study with only 115 participants, so results may not apply broadly. Safety and immune response are still being evaluated.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMAVIRUS INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dodowa Health Research Center
RECRUITINGAccra, Ghana
Contact Phone: •••-•••-•••• Email: •••••@•••••